Arkolith/Insider Trading/ENSC/Form 4

Gower Bob G

DirectorEnsysce Biosciences, Inc. (ENSC) · full profile →Form 4 · filed Feb 1, 2023
Net Buying
Open-Market Buys
$500K
Open-Market Sells
$0
Net Open-Market Flow
$500K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 9, 2022Buy(P)357K$1.40$500K753K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 9, 2022Grant(A)714K——716K

Transaction Codes

P
Open-market purchase
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-23-003343) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML